Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALT: Anti-Inflammatory Treatment after SLT
NCT00981435Phase 4Completed
- Sponsor
- Stanford University
- Start
- Sep 2009
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisolone and ketorolac in Glaucoma (3 arms), sponsored by Stanford University. Primary endpoint: Intraocular Pressure Change at 12 weeks. Started Sep 2009; status: completed.
02
Drugs
prednisoloneketorolac
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT00981435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981435.